Capex Related Published Studies
Well-designed clinical trials related to Capex (Fluocinolone Topical)
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. [2008.09]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.09]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.06.28]
Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. [2006.06]
Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. [2005.07]
Fluocinolone acetonide topical oil for scalp psoriasis. [2004.12]
Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive. [2003.04]
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. [2000.11]
Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. [2000.01]
Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. [1997.01]
Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent. [1988.11]
Well-designed clinical trials possibly related to Capex (Fluocinolone Topical)
The effect of ceramide-containing skin care products on eczema resolution duration. [2008.01]
Intranasal flunisolide treatment in children with adenoidal hypertrophy. [2007.10]
Strength and endurance of the respiratory and handgrip muscles after the use of flunisolide in normal subjects. [2007.07]
A hydroquinone formulation with increased stability and decreased potential for irritation. [2007.06]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis. [2006.12]
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial. [2006.04]
Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. [2006.01]
Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. [2006]
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. [2005.07]
The effect of two skin cleansing systems on moderate xerotic eczema. [2004.06]
A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo. [2004.01]
Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. [2004]
Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis. [2003.09]
A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. [2003.09]
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. [2003.07]
Triple inhaled drug protocol for the treatment of acute severe asthma. [2003.06]
Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. [2002.10]
Multiple-dose proportionality study of flunisolide hydrofluoroalkane. [2002.09]
One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. [2002.06]
Systemic effect comparisons of six inhaled corticosteroid preparations. [2002.05.15]
A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. [2002.03]
Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide. [2002.02]
Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers. [2001.12]
Corticosteroids administered by nebulization to children with bronchial asthma. [2001.11]
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. [2001.11]
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. [2001.11]
[Antiinflammatory effect of a topical corticosteroid: known brand versus generic drug] [2001.07]
Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. [2001.06]
Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. [2000.11]
Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. [2000.07]
Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. [2000.05]
Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolide. [2000.04]
Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group. [2000.03]
Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. [2000.03]
Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. [1999.11]
A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). [1999.08]
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. [1999.02]
Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. [1999.01]
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. [1998.05]
Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices. [1998.04]
Inhaled flunisolide for acute severe asthma. [1998.03]
Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. [1998.03]
Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. [1997.12]
Mometasone furoate 0.1%-salicylic acid 5% ointment twice daily versus fluocinonide 0.05% ointment twice daily in the management of patients with psoriasis. [1997.07]
Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. [1997.03]
The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. [1997.03]
[Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma] [1997.01]
Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer. [1996.09]
New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: comparative assessment of safety, tolerability, and efficacy. [1996.05]
Nebulized flunisolide in infants and young children with asthma: a pilot study. [1996.05]
A bioassay for topical and systemic effect of three inhaled corticosteroids. [1995.04]
Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. [1995.04]
Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis. [1994.11]
Comparative trial of acceptability of beclomethasone dipropionate and a new formulation of flunisolide. [1994.06]
Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. [1994.06]
Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. [1993.12]
Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide, flunisolide, and flunisolide with menthol. [1993.11]
Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. [1993.02]
[Ointment treatment of 1st degree hemorrhoids. Comparison of the effectiveness of a phytogenic preparation with two new ointments containing synthetic drugs] [1992.03.20]
A randomized prospective comparison of two methods of administering topical treatment in otitis externa. [1991.12]
A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay. [1991.02]
Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children. [1990.11]
[Clinico-functional evaluation of flunisolide + salbutamol combination (VAL 679/A) vs salbutamol in pediatric patients] [1990.06]
Evaluation of symptom relief, nasal airflow, nasal cytology, and acceptability of two formulations of flunisolide nasal spray in patients with perennial allergic rhinitis. [1990.06]
Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide. [1989.12]
A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis. [1989.11]
Beclomethasone dipropionate versus flunisolide as topical steroid treatment in patients with perennial rhinitis. [1989.10]
Rhinomanometric evaluation of two nasal steroid sprays in rhinitis. [1989.10]
Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis. [1988.11]
Comparative tolerability of two formulations of Rhinalar (flunisolide) nasal spray in patients with seasonal allergic rhinitis. [1988.10]
Experimentally induced nasal allergic responses. [1988.05]
Are generic formulations equivalent to trade name topical glucocorticoids? [1987.10]
Other research related to Capex (Fluocinolone Topical)
Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis. [2008.10]
Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. [2008.08]
Treatment of serpiginous choroiditis with intravitreous fluocinolone acetonide implant. [2008.05]
Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis. [2008.04]
Stem cells in the hair follicle and interfollicular epidermis of mice following topical application of fluocinolone acetonide. [2007.12]
Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. [2007.11]
Intraocular Pressure in Patients With Uveitis Treated With Fluocinolone Acetonide Implants. [2007.10.08]
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. [2007.02]
Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. [2007.02]
Fluocinolone acetonide intravitreal sustained release device--a new addition to the armamentarium of uveitic management. [2007]
Long-term release of fluocinolone acetonide using biodegradable fumarate-based polymers. [2006.08.28]
Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis. [2006.07]
Expression of TNF-alpha in oral lichen planus treated with fluocinolone acetonide 0.1%. [2006.03]
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. [2005.01]
Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period. [2004.06]
Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. [2003.07]
|
